Colleen P. Gibbons - Concepedia

Author

Colleen P. Gibbons

Also Known As

C. Gibbons, Colleen Gibbons, Colleen P. Gibbons

Publications

641

Citations

H-Index

Concepts

All Affiliations

Colleen P. Gibbons is an author at Pfizer (United States) specializing in medicine, pharmacology, and drug discovery.

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	91
2	Biochemistry	2	2	50
3	Health Sciences	1	1	29
4	Biomolecular Engineering	1	1	12
5	Endocrinology	1	1	29

Colleen P. Gibbons

Publications

632

Citations

H-Index

Page 1

	Year	Citations
Impaired inflammatory and pain responses in mice lacking an inducible prostaglandin E synthase Catherine E. Trebino, Jeffrey L. Stock, Colleen P. Gibbons, Proceedings of the National Academy of Sciences	2003	541
Leptin potentiates the anti-obesity effects of rimonabant Carine M. Boustany‐Kari, V. Margaret Jackson, Colleen P. Gibbons, European Journal of Pharmacology ObesityMetabolic SyndromeMedicineAnti-obesity EffectsPhysiology	2011	29
Structure–activity relationships of triazolopyridine oxazole p38 inhibitors: Identification of candidates for clinical development Kim F. McClure, Michael A. Letavic, Amit S. Kalgutkar, Bioorganic & Medicinal Chemistry Letters BiochemistryMedicineRational Drug DesignMechanism Of ActionClinical Development	2006	28
Design and synthesis of orally-active and selective azaindane 5HT2c agonist for the treatment of obesity Kevin K.‐C. Liu, Peter Cornelius, Terrell A. Patterson, Bioorganic & Medicinal Chemistry Letters Pharmacological StudyBiochemistryMedicineSelective Azaindane 5Ht2cPharmacological Agent	2009	22
Pyrimido[4,5-d]azepines as potent and selective 5-HT2C receptor agonists: Design, synthesis, and evaluation of PF-3246799 as a treatment for urinary incontinence Mark D. Andrews, Paul V. Fish, Julian Blagg, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryMedicineDrug DiscoveryUrinary IncontinencePharmacological Agent	2010	12

Page 1